DetectoGen Inc is organized primarily around development and production of simple, affordable and user friendly diagnostic tests to detect human diseases utilizing non-invasive samples e.g. urine or saliva. Such tests can be used to diagnose a number of serious, but neglected infectious diseases such as leishmaniasis, tuberculosis, and malaria that are typically more coomon in less developed areas of the world. The firm is currently working on development of a urine-based diagnostic test for visceral leishmaniasis (VL). The test detects specific proteins of actively multiplying microorganisms in vivo and thus this test is of particular interest in that it will be highly effective to diagnose active disease. The test can also be used to monitor the efficacy of VL treatment.
